Holywood, United Kingdom

Mehar Manku

This inventor holds 3 USPTO granted patents. Top assignee: Scarista Limited. Active years: 2008-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mehar Manku. Retrieved from https://idiyas.com/inventor/mehar-manku-qlazweyu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 66.7

Average Co-Inventor Count = 8.3

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2008-2012

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Mehar Manku

Introduction

Mehar Manku is a notable inventor based in Hollywood, GB. He has made significant contributions to the field of drug delivery through his innovative inventions. With a total of three patents to his name, Manku is recognized for his work in developing compounds that enhance the efficacy of drug delivery systems.

Latest Patents

Manku's latest patents focus on 1,3-propane diol esters and ethers, along with methods for their use in drug delivery. These inventions relate to compounds where R is selected from fatty acid acyl groups of 12 to 30 carbon atoms and fatty alcohol groups of 12 to 30 carbon atoms. The compounds also include residues of nutrients, drugs, or other bioactive compounds, aimed at improving the delivery of these substances.

Career Highlights

Manku is currently associated with Scarista Limited, where he continues to innovate and develop new solutions in the pharmaceutical field. His work has garnered attention for its potential to revolutionize drug delivery methods.

Collaborations

Some of Manku's notable coworkers include Peter Redden and Paul Wakefield. Their collaborative efforts contribute to the advancement of research and development in their respective fields.

Conclusion

Mehar Manku's contributions to drug delivery through his innovative patents highlight his role as a significant inventor in the industry. His work continues to pave the way for advancements in pharmaceutical technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…